Skip to main content
Clinical Trials/EUCTR2004-001991-37-GB
EUCTR2004-001991-37-GB
Active, not recruiting
Not Applicable

A pilot study investigating the effects of a combination of local and systemic anti-inflammatory adjuncts in patients undergoing vitrectomy and silicone oil for established Proliferative Vitreoretinopathy. - Anti-inflammatories in patients with PVR

Moorfields Eye Hospital0 sites30 target enrollmentJuly 4, 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Proliferative Vitreoretinopathy This is a scarring process that occurs in patients who have developed a retinal detachment. It is the primary cause of failure in retinal detachment surgery and occurs in 5-10% cases.
Sponsor
Moorfields Eye Hospital
Enrollment
30
Status
Active, not recruiting
Last Updated
12 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 4, 2005
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Primary retinal detachment complicated by proliferative vitreoretinopathy with grade equal to or greater than C1\.
  • Classification of PVR as described in:
  • An updated classification of retinal detachment with proliferative vitreoretinopathy. Machemer R, Aarberg TM, Freeman HM et al. Am J Ophthalmol 1991;112(2\):158\-165\.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • 1\) Clinically significant coexisting ocular pathology other than retinal detachment.
  • 2\) Glaucoma, ocular hypertension, steroid responsive glaucoma.
  • 3\) Enrolment in other studies.
  • 4\) Inability to attend regular follow up.
  • 5\) Contraindication to any of the IMP's

Outcomes

Primary Outcomes

Not specified

Similar Trials